Qilian International Holding Group Limited - Total Utang marang Modal QLI

Qilian International Holding Group Limited - logo grafis emiten QLI

The market price action for the individual debt-to-equity ratio of Qilian International (QLI) is visualized for analysis as 0.01. The business procures plant-based components from farmers while maintaining autonomous synthesis at its own facilities. Financial stability is constrained by strict PRC oversight and the volatile cost of antibiotic ingredients. Profits are driven by the export of heparin and licorice, with margins remaining acceptable.

Qilian International Holding (QLI): Rasio Kabeh Utang marang Dana Pribadi saka 04.07.2022 nganti 17.08.2024
Produk dadi qlsyy.net

This ratio measures the proportion of borrowed funds relative to equity, determining the degree of financial leverage and the risk of default should interest rates rise. Analyzing the debt-to-equity ratio for Qilian International (QLI) is critical, as low margins in chemical production and a lack of pricing power leave the business vulnerable to any excessive debt obligations.

Pesaing Qilian International

HLN (Haleon) - Total Utang marang Modal|KVUE: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal VRNA|Total Utang marang Modal Jyong Bio (MENS)|Utang marang Ekuitas Ligand Pharmaceuticals LGND|Rasio Kabeh Utang marang Dana Pribadi AMRX|PRGO - Utang marang Ekuitas|Alvotech S.A. (ALVO) - Rasio Total Utang marang Ekuitas|LQDA: Total Utang marang Modal|Galapagos Corp (GLPG) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas ANIP|MNKD: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX - Utang marang Modal|ARS Pharma - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal TBPH (Theravance Corp)|Aquestive Therapeutics - Total Utang marang Modal|Rasio Kabeh Utang marang Dana Pribadi SCPH (scPharmaceuticals Inc.)|TECX: Total Utang marang Modal|Utang marang Modal Tonix Pharma (TNXP)|Utang marang Ekuitas SXT Pharmaceuticals|EPRX: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas BioHarvest Sciences (BHST)|invizyne.com (EXOZ) - Rasio Utang marang Modal|Total Utang marang Modal ORMP (Oramed Pharmaceuticals Inc.)|Koefisien Total Utang marang Modal Entera Bio Ltd (ENTX)|HYFT - Utang marang Ekuitas|ABVC: Utang marang Ekuitas|CPIX: Total Utang marang Modal|QNTM - Koefisien Total Utang marang Modal|FGEN (FibroGen) - Total Utang marang Modal|Total Utang marang Modal Telomir Pharmaceuticals Inc|Utang marang Ekuitas Rani Therapeutics (RANI)|synergychc.com - Rasio Utang marang Ekuitas|Rallybio - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LEXX|Pulmatrix - Total Utang marang Modal|Koefisien Total Utang marang Modal Pheton Holdings Ltd PTHL|aptorumgroup.com (APM) - Utang marang Ekuitas|Rasio Utang marang Ekuitas LYRA|Rasio Total Utang marang Ekuitas IBO|TNFA (TNF Pharma) - Utang Agregat marang Modal|Total Utang marang Modal YCBD|PRFX - Utang marang Modal|Utang marang Ekuitas Altamira Therapeutics Ltd. CYTO|Rasio Kabeh Utang marang Dana Pribadi LIPO|OPTN - Utang marang Ekuitas|PIRS (pieris.com) - Rasio Utang marang Ekuitas|PROC: Total Utang marang Modal|Petros Pharmaceuticals Inc (PTPI) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas SLRN|TFFP (TFF Pharmaceuticals, Inc) - Utang Agregat marang Modal